Accepted Presentations Showcase First-in-Human Development, Manufacturing Innovation, and Predictive Biomarkers for Deciparticle™ Everolimus ...
Ingelheim: Boehringer Ingelheim has received approval from the U.S. Food and Drug Administration (FDA) for JASCAYD ...
Ensifentrine significantly improved lung function after 12 weeks in patients with moderate to severe COPD with and without ...
Alto Neuroscience Inc. (NYSE:ANRO) is one of the best young stocks with huge upside potential. On October 3, Alto ...
If approved in RCC, fruquintinib will be available for three indications, including endometrial and colorectal cancer.
Stockhead on MSN
Dr Boreham’s Crucible: ED nasal spray innovator arouses interest as it looks to rise again
In drug development, real world evidence can be just as valuable as clinical proof – and in this respect LTR Pharma has ...
NuCana (NCNA) presented data at the European Society for Medical Oncology Congress 2025, ESMO, on a new model system investigating the synergistic ...
Event: LD Micro Main Event XIX Date: Tuesday, October 21st Time: 11:30 ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback